Showing results (361-370 of 586) with videos related to
Sort By:
Pageof 59
Genes and Immunity|October 3, 2009
Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokinesK Witte, G Gruetz, H-D Volk, et al.BMJ Open|July 2, 2016
Submaximal fitness and mortality risk reduction in coronary heart disease: a retrospective cohort study of community-based exercise rehabilitationClaire Taylor, Costas Tsakirides, James Moxon, et al.Journal of General Internal Medicine|July 20, 2018
Effects of Ivabradine on Hemodynamic and Functional Parameters in Left Ventricular Systolic Dysfunction: a Systematic Review and Meta-analysisPeysh A Patel, Noman Ali, Ashwin Roy, et al.The American Journal of Cardiology|May 1, 1985
Effects of combination cholestyramine-neomycin treatment on plasma lipoprotein concentrations in type II hyperlipoproteinemiaJ M Hoeg, M B Maher, K R Bailey, et al.Comprehensive Gerontology. Section A, Clinical and Laboratory Sciences|February 1, 1987
Age-correlated changes in the lupus erythematosus antigens Ro, La, Sm and RNP of the thymus glandW E Müller, W Mayet, M Bachmann, et al.The American Journal of Medicine|September 1, 1983
Massive omental reticuloendothelial cell lipid uptake in Tangier disease after splenectomyE J Schaefer, T J Triche, L A Zech, et al.Journal of Surgical Oncology|November 1, 1996
Pharmacokinetics of dacarbazine in the regional perfusion of extremities with melanomaM S Didolkar, A J Jackson, L J Lesko, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|October 15, 1985
Estimation of VLDL cholesterol in hyperlipidemiaP W Wilson, L A Zech, R E Gregg, et al.The Journal of Clinical Investigation|April 1, 1993
In vivo metabolism of a mutant form of apolipoprotein A-I, apo A-IMilano, associated with familial hypoalphalipoproteinemiaP Roma, R E Gregg, M S Meng, et al.Journal of Lipid Research|May 11, 1992
In vivo metabolism of a mutant apolipoprotein, apoA-IIowa, associated with hypoalphalipoproteinemia and hereditary systemic amyloidosisD J Rader, R E Gregg, M S Meng, et al.Pageof 59